BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 36122895)

  • 1. Engineered biomimetic nanoreactor for synergistic photodynamic-chemotherapy against hypoxic tumor.
    Guo H; Wang L; Wu W; Guo M; Yang L; Zhang Z; Cao L; Pu F; Huang X; Shao Z
    J Control Release; 2022 Nov; 351():151-163. PubMed ID: 36122895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomimetic cell membrane-coated glucose/oxygen-exhausting nanoreactor for remodeling tumor microenvironment in targeted hypoxic tumor therapy.
    Guo H; Zhang W; Wang L; Shao Z; Huang X
    Biomaterials; 2022 Nov; 290():121821. PubMed ID: 36201949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Cancer Chemo-Photodynamic and Photothermal Therapy Based on ICG/PDA/TPZ-Loaded Nanoparticles.
    Huang X; Wu J; He M; Hou X; Wang Y; Cai X; Xin H; Gao F; Chen Y
    Mol Pharm; 2019 May; 16(5):2172-2183. PubMed ID: 30978027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
    Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D
    ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional Theranostic Liposomes Loaded with a Hypoxia-Activated Prodrug for Cascade-Activated Tumor Selective Combination Therapy.
    Dai Y; Wang B; Sun Z; Cheng J; Zhao H; Wu K; Sun P; Shen Q; Li M; Fan Q
    ACS Appl Mater Interfaces; 2019 Oct; 11(43):39410-39423. PubMed ID: 31578854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme/GSH dual-responsive biodegradable nanohybrid for spatiotemporally specific photodynamic and hypoxia-augmented therapy against tumors.
    Cheng D; Ji Y; Wang B; Jin T; Xu Y; Qian X; Zhu W
    Int J Pharm; 2021 Jun; 603():120730. PubMed ID: 34029662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synchronous delivery of oxygen and photosensitizer for alleviation of hypoxia tumor microenvironment and dramatically enhanced photodynamic therapy.
    Guo X; Qu J; Zhu C; Li W; Luo L; Yang J; Yin X; Li Q; Du Y; Chen D; Qiu Y; Lou Y; You J
    Drug Deliv; 2018 Nov; 25(1):585-599. PubMed ID: 29461122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controllable hypoxia-activated chemotherapy as a dual enhancer for synergistic cancer photodynamic immunotherapy.
    Wang M; He M; Zhang M; Xue S; Xu T; Zhao Y; Li D; Zhi F; Ding D
    Biomaterials; 2023 Oct; 301():122257. PubMed ID: 37531778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia and Singlet Oxygen Dual-Responsive Micelles for Photodynamic and Chemotherapy Therapy Featured with Enhanced Cellular Uptake and Triggered Cargo Delivery.
    Guo X; Han L; Chen W; He H; Zhang W; Huang C; Wang X
    Int J Nanomedicine; 2024; 19():247-261. PubMed ID: 38229704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolving Microneedle-Based Cascade-Activation Nanoplatform for Enhanced Photodynamic Therapy of Skin Cancer.
    Ma J; Tai Z; Li Y; Li Y; Wang J; Zhou T; Shen M; Xin R; Shen C; Zhu Q; Chen Z
    Int J Nanomedicine; 2024; 19():2057-2070. PubMed ID: 38482522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing Hypoxia-Sensitive System via Designing Tumor-Targeted Fullerene-Based Photosensitizer for Multimodal Therapy of Deep Tumor.
    Li L; Fu J; Ye J; Liu L; Sun Z; Wang H; Tan S; Zhen M; Wang C; Bai C
    Adv Mater; 2024 Jun; 36(23):e2310875. PubMed ID: 38450765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near-infrared light triggered liposomes combining photodynamic and chemotherapy for synergistic breast tumor therapy.
    Yang Y; Yang X; Li H; Li C; Ding H; Zhang M; Guo Y; Sun M
    Colloids Surf B Biointerfaces; 2019 Jan; 173():564-570. PubMed ID: 30347383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive enhanced photodynamic therapy and enhanced chemotherapy fighting against malignant tumors with sequential drug release.
    Yang Y; Zhang X; Bai Z; Cui Z; Liang W; Zhang J; Li K; Shi M; Liu Z; Wang J; Li J
    Biomed Mater; 2024 May; 19(4):. PubMed ID: 38697132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hybrid metal-organic framework nanomedicine-mediated photodynamic therapy and hypoxia-activated cancer chemotherapy.
    Jia Z; Gao Y; Ni J; Wu X; Mao Z; Sheng G; Zhu Y
    J Colloid Interface Sci; 2023 Jan; 629(Pt B):379-390. PubMed ID: 36162395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy.
    He H; Du L; Xue H; Wu J; Shuai X
    Acta Biomater; 2022 Sep; 149():297-306. PubMed ID: 35811069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of non-toxic GOx-based biocatalytic nanoreactor for multimodal synergistic therapy and tumor metastasis suppression.
    Hang L; Zhang T; Wen H; Li M; Liang L; Tang X; Zhou C; Tian J; Ma X; Jiang G
    Theranostics; 2021; 11(20):10001-10011. PubMed ID: 34815800
    [No Abstract]   [Full Text] [Related]  

  • 17. GSH-Responsive and Hypoxia-Activated Multifunctional Nanoparticles for Synergetically Enhanced Tumor Therapy.
    Liu C; Jia S; Tu L; Yang P; Wang Y; Ke S; Shi W; Ye S
    ACS Biomater Sci Eng; 2022 May; 8(5):1942-1955. PubMed ID: 35357802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting triple-negative breast cancer with an aptamer-functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies.
    Chou YT; Lin CY; Wen JW; Hung LC; Chang YF; Yang CM; Wu LC; Ho JA
    J Nanobiotechnology; 2021 Mar; 19(1):89. PubMed ID: 33781277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy.
    Dong Y; Zhou L; Shen Z; Ma Q; Zhao Y; Sun Y; Cao J
    Drug Deliv; 2022 Dec; 29(1):238-253. PubMed ID: 35001784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized Combination of Photodynamic Therapy and Chemotherapy Using Gelatin Nanoparticles Containing Tirapazamine and Pheophorbide a.
    Lee D; Jang SY; Kwon S; Lee Y; Park E; Koo H
    ACS Appl Mater Interfaces; 2021 Mar; 13(9):10812-10821. PubMed ID: 33624503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.